Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

PRESAMINE

IMIPRAMINE HYDROCHLORIDE

Standard Dose
10MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary

Approval overview PRESAMINE is listed in Drugs@FDA under application 011836 (NDA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient IMIPRAMINE HYDROCHLORIDE Form and strength TABLET;ORAL - 10MG Sponsor SANOFI AVENTIS US Submission history Latest submission status date: 1984-10-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview PRESAMINE is listed in Drugs@FDA under application 011836 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient IMIPRAMINE HYDROCHLORIDE Form and strength TABLET;ORAL - 10MG Sponsor SANOFI AVENTIS US Submission history Latest submission status date: 1984-10-30 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.